SALIM CHERIYAN to Neoadjuvant Therapy
This is a "connection" page, showing publications SALIM CHERIYAN has written about Neoadjuvant Therapy.
Connection Strength
0.078
-
Comparative analysis of three vs. four cycles of neoadjuvant gemcitabine and cisplatin for muscle invasive bladder cancer. Urol Oncol. 2022 10; 40(10):453.e19-453.e26.
Score: 0.044
-
Current controversies and developments on the role of lymphadenectomy for penile cancer. Urol Oncol. 2019 03; 37(3):201-208.
Score: 0.034